1. Home
  2. SONO vs NUVB Comparison

SONO vs NUVB Comparison

Compare SONO & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$19.03

Market Cap

2.2B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.62

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
NUVB
Founded
2002
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SONO
NUVB
Price
$19.03
$8.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$17.00
$9.63
AVG Volume (30 Days)
1.6M
10.2M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,443,276,000.00
$26,748,000.00
Revenue This Year
$4.35
$283.17
Revenue Next Year
$7.90
$340.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1137.19
52 Week Low
$7.63
$1.54
52 Week High
$19.15
$8.70

Technical Indicators

Market Signals
Indicator
SONO
NUVB
Relative Strength Index (RSI) 66.78 76.08
Support Level $18.16 $7.46
Resistance Level $19.07 $8.24
Average True Range (ATR) 0.65 0.62
MACD 0.19 0.13
Stochastic Oscillator 96.07 97.20

Price Performance

Historical Comparison
SONO
NUVB

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: